Progress in Prophylactic and Therapeutic EBV Vaccine Development Based on Molecular Characteristics of EBV Target Antigens

Epstein–Barr virus (EBV) was discovered in 1964 in the cell line of Burkitt lymphoma and became first known human oncogenic virus. EBV belongs to the Herpesviridae family, and is present worldwide as it infects 95% of people. Infection with EBV usually happens during childhood when it remains asympt...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozman, Marija, Korać, Petra, Jambrosic, Karlo, Židovec Lepej, Snjezana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414479/
https://www.ncbi.nlm.nih.gov/pubmed/36014985
http://dx.doi.org/10.3390/pathogens11080864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414479/
https://www.ncbi.nlm.nih.gov/pubmed/36014985
http://dx.doi.org/10.3390/pathogens11080864

Ejemplares similares